Hopes for a drug that could inhibit colorectal cancer took a knock last year due to revelations of serious side-effects. But a combination therapy may now offer a way forward.
Could COX-2s stage a comeback in cancer?
Janet Fricker
Related Articles
Senza categoria
NEWSROUND
Focus
Angiogenesis inhibition: do tumours have a plan B?
Impact Factor
Leave a Reply